Clinical trials - information for sponsors

Why choose South Australia?

South Australia is home to world class researchers and clinical trial facilities making it an ideal location to conduct clinical trials. 

Adelaide BioMed City is one of the largest health and life sciences clusters in the southern hemisphere bringing together institutions from research, education and clinical care.

Adelaide offers:

  • No investigational new drug (IND) requirements
  • Preclinical, Phase 1, Phase 2 and Phase 3 facilities
  • World class infrastructure and expertise
  • Large and diverse patient populations
  • Ethics committees certified to approve all phases of clinical research.

Australia has an efficient regulatory approval framework in the Clinical Trials Notification (CTN) scheme administered by the Therapeutic Goods Administration (TGA).  This process eliminates the requirement for the Investigational New Drug requirements.

The Australian Government offers a Research and development (R&D) tax incentive by providing up to 43.5% cashback for eligible R&D expenditure. Further information can be found on the Australian Government Research and development tax incentive page.

Clinical trials in Adelaide are compliant with International Conference on Harmonisation (ICH) Good Clinical Practice (GCP).  This means that Australian clinical trials will be compliant with the US Food and Drug Administration (FDA), European Medicines Agency (EMA), and Japanese and Canadian regulatory bodies.

Further information

For more information please contact email Health.DHAResearch@sa.gov.au